2Maini RN,Breedveld FC.Sustained improvement over two years in physical function,structural damage,and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate[J].Arthritis Rheum,2004,50(4):1051.
3Iain BM,Georg S. Cytokines in the pathogenesis of rheu- matoid arthritis[J]. Nature Reviews Immunology, 2007,7 (3):429-442.
4van OM, Levarht EW, Sont JK, et al. Ciiaical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12[J]. Ann Rheum Dis,2005,64(4) :537-543.
5van VRF,Geborek P, Forslind K, et al. Conventional com- bination treatment versus biological treatment in methotrex- ate- refractory early rheumatoid arthritis :2 year follow-up of the randomised, non-blinded, parallel- group Swefot trial[J]. Lancet, 2012,379 (9827):1712- 1720.
6Antony T,Jose VM,Paul BJ,et al. Efficacy and safety of leflunomide alone and in combination with methotrexate in the treatment of refractory rheumatoid arthritis[J]. In- dian J Med Sci,2006,60(8) :318-326.
7Kekow J, Moots R J, Emery P, et al. Patient-reported out comes improve with etanercept plus methotrexate in ac- tive early rheumatoid arthritis and the improvement is strongly associated with remission:the COMET trial[J]. Ann Rheum Dis,2010,69(1) :222-225.
8Symmons DP,Silman AJ. The world of biologics[J]. Lu- pus, 2006,15 (3) : 122-126.
9Clelland S, Hunek JR. Etanercept injection site reaction [J].Dermatology Nursing, 2005,17 (5) : 375-380.
